|
⚲
|
| Keyboard |
| Novogen Ltd
✚
|
|
|---|---|
| CIK # | 0001075880 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001075880] | |
| 4 | [0001075880] | |
| 6-K | [0001075880] | |
| D | [0001075880] | |
| SC 13G | [0001075880] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Apple Robert F | |
| Kazia Therapeutics Ltd | |
| Coffey Steven R S | |
| Friend John E II | |
| Bonacorda Jeffrey | |
| Davidson Ebru | |
| Cain David | |
| Rao Sudha | |
| Levine James E | |
| Simpson Jeremy | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kazia Therapeutics Ltd NVGN
Sponsored ADRs, each convertible into 25 ordinary shares
|
2013-11-05 | Sell | 23,922 | $6.01 | 143,771 |
|
Kazia Therapeutics Ltd NVGN
Sponsored ADRs, each convertible into 25 ordinary shares
|
2013-11-04 | Sell | 25,400 | $6.02 | 152,908 |
|
Kazia Therapeutics Ltd NVGN
Sponsored ADRs, each convertible into 25 ordinary shares
|
2013-10-29 | Sell | 1,100 | $6.04 | 6,644 |
|
Kazia Therapeutics Ltd NVGN
Sponsored ADRs, each convertible into 25 ordinary shares
|
2013-10-28 | Sell | 37,409 | $6.18 | 231,188 |
|
Kazia Therapeutics Ltd NVGN
Sponsored ADRs, each convertible into 25 ordinary shares
|
2013-10-25 | Sell | 62,591 | $6.17 | 386,186 |
|
Kazia Therapeutics Ltd NVGN
Sponsored ADRs, each convertible into 25 ordinary shares
|
2013-10-15 | Sell | 90,025 | $6.21 | 559,055 |
|
Kazia Therapeutics Ltd NVGN
Sponsored ADRs, each convertible into 25 ordinary shares
|
2013-02-26 | Sell | 500 | $8.00 | 4,000 |
|
Kazia Therapeutics Ltd NVGN
Sponsored ADRs, each convertible into 25 ordinary shares
|
2013-02-25 | Sell | 500 | $9.03 | 4,515 |
|
Kazia Therapeutics Ltd NVGN
Sponsored ADRs, each convertible into 25 ordinary shares
|
2013-02-25 | Sell | 500 | $8.90 | 4,450 |
|
Kazia Therapeutics Ltd NVGN
Sponsored ADRs, each convertible into 25 ordinary shares
|
2013-02-25 | Sell | 500 | $9.05 | 4,525 |
|
Kazia Therapeutics Ltd NVGN
Sponsored ADRs, each convertible into 25 ordinary shares
|
2013-02-25 | Sell | 500 | $9.10 | 4,550 |
|
Kazia Therapeutics Ltd NVGN
Sponsored ADRs, each convertible into 25 ordinary shares
|
2013-02-25 | Sell | 500 | $9.21 | 4,605 |
|
Kazia Therapeutics Ltd NVGN
Sponsored ADRs, each convertible into 25 ordinary shares
|
2013-02-25 | Sell | 500 | $9.15 | 4,575 |
|
Marshall Edwards Inc MEIP
Common stock, par value $0.00000002 per share
|
2012-12-03 | Other | 17,837,246 | $0.00 | |
|
Marshall Edwards Inc MEIP
Common stock, par value $0.00000002 per share
|
2012-11-20 | Conversion | 4,827,000 | $0.00 | |
|
Marshall Edwards Inc MEIP
Series A Convert Preferred Stock, par value $0.01 per share · derivative
|
2012-11-20 | Conversion | 1,000 | $0.00 | |
|
Marshall Edwards Inc MSHL
Common stock, par value $0.00000002 per share
|
2012-05-11 | Option exercise | 4,494,377 | $0.89 | 3,999,996 |
|
Marshall Edwards Inc MSHL
Warrants to purchase shares of common stock · derivative
|
2012-05-11 | Option exercise | 2,247,168 | $0.89 | 1,999,980 |
|
Marshall Edwards Inc MSHL
Subscription rights (right to buy) · derivative
|
2012-05-11 | Option exercise | 8,988,675 | $0.00 |